Yearly Archives: 2015

For the USC Center for Health Journalism, Martha Rosenberg points out the absurdity of allowing industry funded doctors to teach classes to practitioners about psychiatric drugs. "What if the written road test drivers take were sponsored by BP or Shell and had marketing messages interspersed?"

Oryx Cohen at TruthOut explains why the "Helping Families in Mental Health Crisis Act (HR 2646) - commonly known as the 'Murphy Bill' - appears to cater more closely to the desires of pharmaceutical companies than to the actual needs of people in psychological distress, perhaps because of Murphy's connections to key lobbyists." "If the Murphy Bill is passed, psychiatric hospitals and pharmaceutical companies will reap huge financial benefits as a result of increased hospitalization and forced treatment."

In graduate school at UT Austin, while engaging in electroconvulsive treatment, my academic advisor would refer to my resiliency. That I suited up, showed up. Graduate school gave me something to hang onto and to busy myself with intellectually; something that was rooted firmly, concretely, in time and space. But most of all it allowed structure back into my world. Conversely, while ECT was a last-breath attempt to abate all further SI (self-injury) attempts, it was intensive and invasive, affecting my cognitive abilities. I struggled with draft after draft for multiple coursework papers.

Thousands push the limits (their own and the system’s) on a daily basis to fight the oppression of individuals labeled with psychiatric diagnoses, and to change the way the world understands various kinds of distress. Some of us call the body of people engaged in this work a ‘movement’. I am one such person who is often referring to a ‘civil rights’ or ‘human rights’ movement within this context, although I recognize the problems with referencing a singular ‘movement’, as well.

I don't know about you, but sound, audio, music, making mixes on spotify, catching up on my favorite standards on pandora keeps me well...

Dennis D. Embry is a prominent prevention scientist in the United States and Canada, trained as clinician and developmental and child psychologist. He is...

Depression and anxiety can be symptoms that are like a throbbing toe. Did you just drop a hammer on it? Is there a string wrapped tightly around it? Is the toenail infected? There’s pain, but what from? What might it mean? If you ask why, psychiatry has a well-rehearsed answer for you: it’s your broken brain and your misfiring chemistry! Despite efforts to focus on the danger of our emotional experiences, the finger is now being pointed back at psychiatry to explain why violence and self-harm are documented effects of treatment.

While making money from the publication of pharmaceutical company trials, and in the face of a complete failure by industry to adhere to basic scientific norms and make data available, BMJ and other journals — although BMJ in particular — have run a series of articles on supposed Academic Fraud. These articles feature instances of fraud sometimes as bizarre as researcher claiming he cannot show the data as it was eaten by termites. The universal feature is that these are academic studies, and academic fraud is an issue in academia.

From 1999 to 2012 the percentage of Americans on antidepressants increased from 6.8% to 13%, according to a report published this week by the...

Dennis D. Embry, PhD, was responsible for drafting the letter signed by 23 scientists, who collectively represent scores of randomized prevention trials of mental illnesses...

I’ve come to realize that the very good intentions of Congressman Murphy to fix an obviously not-working mental health prevention, intervention, and treatment “system” has caused him to be swarmed by a flock of flatterers flogging fraudulent “facts.” Thus, at the behest of my colleague, I wrote a letter to Congressman Murphy, who is obviously a leader for issues of mental health. My letter was delivered to him personally, and I share much of it here. The more I thought about the pickle the Congressman is in—surrounded by people either flattering him or yelling at him—the more compassion I have for him as a human trying thread his way through the siren songs.

Dennis D. Embry is a prominent prevention scientist in the United States and Canada, trained as clinician and developmental and child psychologist. He is...

The German news agency DW features a video report on whether cannabidiol, an active substance derived from marijuana, can help relieve the symptoms of schizophrenia.

New York Times columnist, Nicholas Kristof, relates the story of Andrew Francesco, a boy who began taking Ritalin at age five and died from complications with Seroquel when he was fifteen. His father, a former pharmaceutical industry executive, reveals the industry’s greed in his memoir “Overmedicated and Undertreated.” Now the industry is pushing for a first-amendment right to market its drugs for off-label uses.

The National Institute of Mental Health (NIMH) is increasingly shifting its research emphasis toward attempting to uncover biomarkers for “mental diseases,” which may have dramatic consequences for research and training in clinical psychology. In an article to be published in next month’s Professional Psychology: Research and Practice, Marvin Goldfried outlines how the shift in funding priorities for psychological research is tied to the needs of pharmaceutical companies and the biological model in psychiatry.

Two companies have committed to FDA review for video games that they claim can be used to treat “ADHD,” but many scientists remain skeptical. “At the annual meeting of the American Academy of Child & Adolescent Psychiatry on Wednesday, Akili Interactive Labs presented data from a pilot study of its video game, Project: EVO, that showed some positive results in children with attention-deficit hyperactivity disorder (ADHD).”

Mad Studies is emerging as a new academic discipline in Canada and proponents are challenging popular conceptions of “madness” and the medicalization human experiences.

For those of us who have been labeled by medical model psychiatry, it is frightening to watch the wolf of social prejudice being cloaked in the guise of mental health reform. The reality for many of us is that our lives and well-being have been profoundly affected – not only by the bad science and good marketing of pharmaceutical companies - but also by a wholesale refusal to listen. The result is a mental health system that many of us do not trust to operate in good faith. The Murphy bills add fuel to this fire.

In 2014, then National Institute of Mental Health (NIMH) director, Thomas Insel, speculated that ketamine “might be the most important breakthrough in antidepressant treatment in decades.” A recent review of the research suggests that while ketamine may produce a rapid short-term improvement in depression, the effect is short-lived and the potential for addiction and dependence warrants considerable caution.

Dear Reader, I am reaching out to you in the hope that you will get this message in time to act! Even if you only have time to read the first two sentences of this blog, please click here for instructions on how you can win the hearts and minds of our federal legislators and help them understand why HR 2646 – proposed by Rep. Tim Murphy and called the Helping Families in Mental Health Crisis Act – is a bad bill

As the UK debates whether to ban smoking inside and outside of mental health hospitals, the BMJ has solicited opinion pieces on the debate for an upcoming issue. However, psychiatric survivors have come forward alleging that the BMJ refused to print their pieces unless they removed descriptions of forced treatment and coercive care.

Legislation is being advanced that would speed up the FDA’s approval process for new drugs and medical devices, according to a report by the Pacific Standard. Pharmaceutical and medical device companies have been lobbying heavily to reduce regulations and are winning over bipartisan support by attaching these measures to increased mental health funding.

The Boston Herald reports on mental health care reform bills moving through both houses of Congress. Lawmakers warn, however, “that some aspects of the legislation could create greater barriers to access mental health care for some.”

At Alternet, Jay Syrmopoulos of The Free Thought Project discusses new research on the use of medical marijuana as a treatment for ADHD within the context of the ongoing debate over the validity of the ADHD diagnosis.

Nature magazine reports on recent discoveries by neuroscientists that microbes that live in the intestinal track may have an influence on brain development and behavior. “Researchers have drawn links between gastrointestinal pathology and psychiatric neurological conditions such as anxiety, depression, autism, schizophrenia and neurodegenerative disorders—but they are just links.”